Leung Ka Lau, Kwok Samuel P Y, Lam Steve C W, Lee Janet F Y, Yiu Raymond Y C, Ng Simon S M, Lai Paul B S, Lau Wan Yee
Department of Surgery, the Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong.
Lancet. 2004 Apr 10;363(9416):1187-92. doi: 10.1016/S0140-6736(04)15947-3.
Although laparoscopic resection of colorectal carcinoma improves post-operative recovery, long-term survival and disease control are the determining factors for its application. We aimed to test the null hypothesis that there was no difference in survival after laparoscopic and open resection for rectosigmoid cancer.
From Sept 21, 1993, to Oct 21, 2002, 403 patients with rectosigmoid carcinoma were randomised to receive either laparoscopic assisted (n=203) or conventional open (n=200) resection of the tumour. Survival and disease-free interval were the main endpoints. Patients were last followed-up in March, 2003. Perioperative data were recorded and direct cost of operation estimated. Data were analysed by intention to treat.
The demographic data of the two groups were similar. After curative resection, the probabilities of survival at 5 years of the laparoscopic and open resection groups were 76.1% (SE 3.7%) and 72.9% (4.0%) respectively. The probabilities of being disease free at 5 years were 75.3% (3.7%) and 78.3% (3.7%), respectively. The operative time of the laparoscopic group was significantly longer, whereas postoperative recovery was significantly better than for the open resection group, but these benefits were at the expense of higher direct cost. The distal margin, the number of lymph nodes found in the resected specimen, overall morbidity and operative mortality did not differ between groups.
Laparoscopic resection of rectosigmoid carcinoma does not jeopardise survival and disease control of patients. The justification for adoption of laparoscopic technique would depend on the perceived value of its effectiveness in improving short-term post-operative outcomes.
尽管腹腔镜结直肠癌切除术可改善术后恢复情况,但长期生存和疾病控制是其应用的决定性因素。我们旨在检验腹腔镜与开放手术切除乙状结肠癌后生存率无差异这一零假设。
从1993年9月21日至2002年10月21日,403例乙状结肠癌患者被随机分为两组,分别接受腹腔镜辅助肿瘤切除术(n = 203)或传统开放肿瘤切除术(n = 200)。生存和无病间期是主要终点。患者最后一次随访时间为2003年3月。记录围手术期数据并估算手术直接费用。采用意向性分析方法对数据进行分析。
两组的人口统计学数据相似。根治性切除术后,腹腔镜手术组和开放手术组的5年生存率分别为76.1%(标准误3.7%)和72.9%(4.0%)。5年无病生存率分别为75.3%(3.7%)和78.3%(3.7%)。腹腔镜手术组的手术时间明显更长,而术后恢复情况明显优于开放手术组,但这些优势是以更高的直接费用为代价的。两组的远切缘、切除标本中发现的淋巴结数量、总体发病率和手术死亡率无差异。
腹腔镜乙状结肠癌切除术不会危及患者的生存和疾病控制。采用腹腔镜技术的理由将取决于其在改善术后短期结局方面的有效性的感知价值。